Trial record 1 of 1 for:    shrinc
Previous Study | Return to List | Next Study

Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage (SHRINC)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2013 by The University of Texas Health Science Center, Houston.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Nicole Gonzales, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT00827892
First received: January 21, 2009
Last updated: May 16, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)